miR-2013 negatively regulates phylogenetically conserved PIP5K involved in TLR4 mediated immune responses of amphioxus (Branchiostoma belcheri Tsingtaunese)

Copyright © 2022 Elsevier Ltd. All rights reserved..

Phosphatidylinositol 4-phosphate 5-kinase (PIP5K) is a catalytic kinase that performs multiple functions in organisms. Recent studies have shown that PIP5Kα in mammals can directly participate in the TLR-mediated innate immune regulation by controlling the production of PIP2. However, the PIP5K homologous gene has not been identified in Cephalochordata to date. In this study, we firstly identify and characterize a new PIP5K family member (designed as AmphiPIP5K) from Cephalochordata amphioxus (Branchiostoma belcheri tsingtaunese), particularly AmphiPIP5K is orthologous with vertebrate PIP5Kα and paralogous with PIP5Kβ and PIP5Kγ. Secondly, we find that the AmphiPIP5K is involved in amphioxus innate immune response to LPS stimulation. Thirdly, our results demonstrate that miR-2013 can inhibit AmphiPIP5K expression by binding to the CDS and 3' UTR regions of AmphiPIP5K. Collectively, our work not only demonstrates the evolutionary pattern of amphioxus PIP5K, but also reveals that miR-2013 negatively regulate PIP5K expression to involve in amphioxus innate immune response.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:133

Enthalten in:

Developmental and comparative immunology - 133(2022) vom: 01. Aug., Seite 104430

Sprache:

Englisch

Beteiligte Personen:

Cao, Yunpeng [VerfasserIn]
Fang, Tao [VerfasserIn]
Du, Yongxin [VerfasserIn]
Li, Ranting [VerfasserIn]
Fan, Mingli [VerfasserIn]
Ma, Fei [VerfasserIn]
Jin, Ping [VerfasserIn]

Links:

Volltext

Themen:

Branchiostoma belcheri tsingtaunese
Evolution
Innate immune
Journal Article
MiR-2013
MicroRNAs
Phosphates
Phosphatidylinositol 4-phosphate 5-kinase (PIP5K)
Research Support, Non-U.S. Gov't
Toll-Like Receptor 4

Anmerkungen:

Date Completed 03.06.2022

Date Revised 09.08.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.dci.2022.104430

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM340296313